Tagged with Obesity

Brij Mohan – President, Diabetes & Obesity Centre, India
Diabetes & Obesity in Portugal: Countering a Rising Threat
Novo Nordisk Portugal’s Paula Barriga: Thriving Under the Spotlight
Eracal: A Swiss Biotech Ahead of the Obesity Curve
Carolina Neves – Deputy Clinical Director, APDP, Portugal
Vikrant Shrotiya – Corporate Vice President & Managing Director, Novo Nordisk India
Zealand Pharma’s New Obesity Focus Leads to 63% Jump in Market Value
Eli Lilly: The World’s First Trillion-Dollar Pharma Company?
Four Insights on Wegovy & The Future of Obesity Treatment from Novo Nordisk CEO Lars Fruergaard Jørgensen
Olympios Papadimitriou – General Manager, Novo Nordisk Greece
Allan Finkel – SVP LatAm, Novo Nordisk
Nabil Daoud – President & General Manager, Spain-Portugal-Greece, Lilly
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here